Cart
sales@molnova.com
Home - Products - Angiogenesis - EGFR - 7,8-Dihydroxyflavone

7,8-Dihydroxyflavone

CAS No. 38183-03-8

7,8-Dihydroxyflavone( 7,8-Dihydroxyflavone | DHF )

Catalog No. M18494 CAS No. 38183-03-8

7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
10MG 29 In Stock
50MG 63 In Stock
100MG 84 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    7,8-Dihydroxyflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    7, 8-Dihydroxyflavone (7, 8-DHF) is a naturally-occurring flavone and exist in Tridax procumbens, Godmania aesculifolia, and primula tree leaves.
  • Description
    7,8-Dihydroxyflavone is an agonist of tyrosine receptor kinase B (TrkB). It acts by promoting immature neuron survival after TBI through activation of the BDNF signaling pathway.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    7,8-Dihydroxyflavone | DHF
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    TrkB
  • Research Area
    Metabolic Disease|Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    38183-03-8
  • Formula Weight
    254.24
  • Molecular Formula
    C15H10O4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 100 mg/mL; 393.33 mM
  • SMILES
    c1ccc(cc1)c1cc(=O)c2c(o1)c(c(cc2)O)O
  • Chemical Name
    7,8-Dihydroxy-2-phenyl-chromen-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Lee RH, et al. Oncol Rep. 2015 Feb;33(2):631-8.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Tyrphostin A1

    Tyrphostin A1 is an inhibitor of EGFR tyrosine kinase .

  • Nimotuzumab

    Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).

  • Selatinib

    Selatinib is an orally active and potent dual inhibitor of EGFR and ErbB2 with anticancer activity that inhibits the growth of NCI-N87 tumor cells.

Sign In Join Free